Sabrina Dunbar | executive |
Katherine Stueland | executive |
Kevin Feeley | executive |
Daniel Brennan | analyst |
William Bonello | analyst |
Mark Massaro | analyst |
Matthew Sykes | analyst |
Brandon Couillard | analyst |
Matthew Stanton | analyst |
Thank you for standing by, and welcome to the GeneDx Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Keep in mind that this call is being recorded. [Operator Instructions] I would now like to turn the call over to Sabrina Dunbar, Investor Relations. Please go ahead.
Thank you, operator, and thank you to everyone for joining us today.